🇺🇸 FDA
Patent

US 9211275

Ketone bodies and ketone body esters as blood lipid lowering agents

granted A61KA61K31/047A61K31/19

Quick answer

US patent 9211275 (Ketone bodies and ketone body esters as blood lipid lowering agents) held by The United States of America, as represented by the Secretary of the Department of Health and Human Services (DHSS) expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of the Department of Health and Human Services (DHSS)
Grant date
Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/047, A61K31/19, A61K31/22, A61K31/365